Zylbrisq prefilled syringe’s usability for generalized MG confirmed
The prefilled syringe used to administer Zylbrysq (zilucoplan) under the skin, or subcutaneously, can be safely and effectively used by generalized myasthenia gravis (gMG) patients, caregivers, and healthcare providers, a usability study in the U.S. shows. Most participants were able to use the syringe, which contained a placebo…